Abstract
Micronization of the pharmaceutical substance levofloxacin hemihydrate (LFC) was studied by the RESS method with trifluoromethane (CHF3) as a polar supercritical solvent. Scanning electron microscopy showed that, at a CHF3 temperature of 50°C, particles of micronized LFC have the shape of microgranules of submicron size. At a temperature of 100°C, the particles take the shape of thin (less than 0.1-μm-thick) elongated plates with rounded edges. At this temperature, an increase in the CHF3 pressure from 20 to 35 MPa leads to an increase in the average particle size from 1 to 2 μm, respectively. X-ray powder diffraction analysis of samples obtained at a temperature of 50°C determined the identity of the original and micronized LFC substances, which correspond to the structure of levofloxacin hemihydrate C36H40F2N6O8⋅H2O. An increase in the process temperature to 100°C leads to the formation of one of pseudopolymorphs of levofloxacin—levofloxacin monohydrate C18H20F2N3O4⋅H2O—in the micronized LFC.
![](http://media.springernature.com/m312/springer-static/image/art%3A10.1134%2FS199079312308002X/MediaObjects/11826_2024_8893_Fig1_HTML.png)
![](http://media.springernature.com/m312/springer-static/image/art%3A10.1134%2FS199079312308002X/MediaObjects/11826_2024_8893_Fig2_HTML.png)
![](http://media.springernature.com/m312/springer-static/image/art%3A10.1134%2FS199079312308002X/MediaObjects/11826_2024_8893_Fig3_HTML.png)
![](http://media.springernature.com/m312/springer-static/image/art%3A10.1134%2FS199079312308002X/MediaObjects/11826_2024_8893_Fig4_HTML.png)
![](http://media.springernature.com/m312/springer-static/image/art%3A10.1134%2FS199079312308002X/MediaObjects/11826_2024_8893_Fig5_HTML.png)
REFERENCES
A. Srivastava, T. Yadav, S. Sharma, A. Nayak, A. Kumari, and N. Mishra, J. Biosci. Med. 4, 69 (2016).
S. Fredenberg, M. Wahlgren, M. Reslow, and A. Axelsson, Int. J. Pharmaceut. 415 (34), 2011.
Design of Controlled Release Drug Delivery Systems, Ed. by X. Li and B. R. Jasti (Hill-McGraw, New York, 2006).
K. Park, J. Controlled Release 190 (3), 2014.
D. S. North, D. N. Fish, and J. J. Redington, Pharmacotherapy 18 (915), 1998.
Zhi Hui Loh, Asim Kumar Samanta, and Paul Wan Sia Heng, Asian J. Pharmaceut. Sci. 10 (255), 2015.
E. Reverchon and R. J. Adami, J. Supercrit. Fluids 37 (1), 1 (2006).
I. Pasquali and R. Bettini, Int. J. Pharm. 364 (176), 2008.
A. M. Vorobei, A.G. Fedorovskiy, M.O. Kostenko, Ya. I. Zuev, and O.O. Parenago, Russ. J. Phys. Chem. B 16 (1416), 2022. https://doi.org/10.1134/S1990793122080152
E. Revershon, J. Supercrit. Fluids. 15 (1), 1999.
R. Chim, S. Marceneiro, M. E. M. Braga, A. M. A. Dias, and H. C. de Sousa, Fluid Phase Equilibria 331 (6), 2012.
E. N. Antonov, L. I. Krotova, G. V. Mishakov, and V. K. Popov, Russ. J. Phys. Chem. B 14 (1225), 2020. https://doi.org/10.1134/S1990793120070210
E. N. Antonov, L. I. Krotova, G. V. Mishakov, and V. K. Popov, Russ. J. Phys. Chem. B 15 (1281), 2021. https://doi.org/10.1134/S1990793121080091
PubChem. Levofloxacin. https://pubchem.ncbi.nlm. nih.gov/compound/Levofloxacin#section=Structures.
Research Services Branch. https://imagej.nih.gov/.
W. H. Walton, Nature 162 (329), 1948.
Ning Wei, Lina Jia, Zeren Shang, Junbo Gong, Songgu Wu, **gkang Wang, and Weiwei Tang, CrystEngComm 21 (6196), 2019.
T. Shinozaki, M. Ono, K. Higashi, and K. Moribe, J. Pharm. Sci. 108 (2383), 2019.
E.M. Gorman, B. Samas, and E.J. Munson, J. Pharm. Sci. 101 (9), 3319 (2012).
I. Nugrahani, M.R. Sulaiman, C. Eda, H. Uekusa, and S. Ibrahim, Pharmaceutics 15 (1), 124 (2023).
H. Kitaoka, C. Wada, R. Morrot, and H. Hakusui, Chem. Pharm. Bull. 43 (4), 649 (1995).
ACKNOWLEDGMENTS
This work was carried out within the framework of the state assignment for the Federal Research Center “Crystallography and Photonics,” Russian Academy of Sciences, Moscow, Russia. The X-ray powder diffraction analysis was performed using equipment of the Center for Shared Use of Scientific Equipment, Federal Research Center “Crystallography and Photonics,” Russian Academy of Sciences, Moscow, Russia.
Funding
This work was supported by ongoing institutional funding. No additional grants to carry out or direct this particular research were obtained.
Author information
Authors and Affiliations
Corresponding author
Ethics declarations
The authors of this work declare that they have no conflicts of interest.
Additional information
Translated by V. Glyanchenko
Publisher’s Note.
Pleiades Publishing remains neutral with regard to jurisdictional claims in published maps and institutional affiliations.
Rights and permissions
About this article
Cite this article
Antonov, E.N., Ivanova, A.G., Krotova, L.I. et al. Micronization of Levofloxacin Hemihydrate Using Supercritical Trifluoromethane. Russ. J. Phys. Chem. B 17, 1555–1560 (2023). https://doi.org/10.1134/S199079312308002X
Received:
Revised:
Accepted:
Published:
Issue Date:
DOI: https://doi.org/10.1134/S199079312308002X